ARCHIVES

Radium-233 Dichloride Increased Overall Survival in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

ASCO Board Accepts Plan To Establish New Bethesda Headquarters, Hire Chief Officer

April 23, 1993

Protocols Approved During the Month of June 2002

July 26, 2002

Anil Potti Resigns From Duke University

November 19, 2010

Cancer Organizations Continue Reform Lobbying: Target Issue Are Off-Label Drugs, Clinical Trials

March 26, 1993

Wilding named director, Univ. of Wisconsin Cancer Center.

January 30, 2004

DCT Board Gives Concept Approval to “National Drug Discovery Groups,” Suggests Four At $1 Million Each

June 11, 1982